Anthropic is racing toward a public debut in September with a healthcare AI pitch that could ignite a sector most investors are not watching. Five biotech names are already moving, and one has climbed…
Three household names are days away from their ex-dividend dates, and missing the cutoff by even one session means that specific cash payment goes to someone else. The clock is running on MSFT, AMGN,…
A sliding dollar is turning foreign dividend payments into a surprising windfall for American retirees, and one international ETF sits right at the center of that currency trade. The question is whether the income…
Friday's Argus upgrade sent SpaceX stock soaring 11%, but Tuesday's tape is telling a different story as post-IPO supply pressures resurface and prediction markets assign a 92.5% chance of a down close.
Kopin is posting one of its sharpest single-session surges of the year after pairing a revenue beat with a partnership that could push its MicroLED technology into a market most investors never expected it…
Palantir just delivered a quarter that broke every model, and even skeptics are struggling to explain away what the numbers show. Here is why the stock may have further to run than almost anyone…
SpaceX just unveiled plans for a factory 15 times the size of the Pentagon, and its stated goal is to shatter the memory chip oligopoly. That ambition forces a hard choice for retirement investors…
Riot Platforms has already handed long-term holders a massive year-to-date gain, yet Wall Street analysts and a proprietary model are pointing to a target that would still more than double the current share price.…
AXT has surged over 350% this year riding the AI optical wave, but tonight Lumentum reports earnings and its commentary on next-generation datacenter connectivity could either validate that run or trigger another painful reversal…
Costco runs one of the most airtight business models in retail, yet the stock is going nowhere fast. What happens when a near-perfect company runs out of room to surprise the market?
Legend Biotech just posted a quarter that flipped a key narrative for LEGN shareholders, but with a CEO transition underway and the stock still down sharply over the past year, the real question is…
A blowout quarter from a key semiconductor peer and a blockbuster Wall Street financing deal sent Onto Innovation surging Tuesday, and the reasons behind the rally suggest the move could be just the beginning.
Jensen Huang just unveiled a financing framework that sent the three biggest cloud companies into the red, and the reason why reveals a seismic shift in who controls the future of AI infrastructure.
Three Fed rate cuts transformed FDRR from a timely bet into a potential mismatch, and income investors holding it may not realize what they actually own beneath the dividend label.
Strategy holds nearly a million Bitcoin while trading at a fraction of last year's price, and the question dividing Wall Street is whether the capital-markets engine that makes it compelling is the same one…
